Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Keybanc Upgrades ResMed to Overweight, Announces $302 Price Target

Keybanc analyst Matthew Mishan upgrades ResMed (NYSE:RMD) from Sector Weight to Overweight and announces $302 price target.
byBenzinga Newsdesk
December 21, 2021
1 minute read
Total
0
Shares
0
0
0
0
0
0

Keybanc analyst Matthew Mishan upgrades ResMed (NYSE:RMD) from Sector Weight to Overweight and announces $302 price target.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0